EU/3/03/160

  • Email
  • Help

Orphan designation

Key facts

Product details for <p>Antisense oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT)</p>
Active substanceAntisense oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT)
Medicine Name
Disease/conditionTreatment of retinopathy of prematurity
Date of decision02/10/2003
OutcomePositive
Orphan decision numberEU/3/03/160

Review of designation